Aduro BioTech's Series B - III Round

Aduro BioTech raised a round of funding on September 10, 2013. Investors include Morningside Ventures.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine platforms. The company is also advancing a n…

Articles about Aduro BioTech's Series B - III Round: